These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25092823)

  • 21. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An RT-PCR panel for rapid serotyping of dengue virus serotypes 1 to 4 in human serum and mosquito on a field-deployable PCR system.
    Tsai JJ; Liu WL; Lin PC; Huang BY; Tsai CY; Chou PH; Lee FC; Ping CF; Lee PA; Liu LT; Chen CH
    PLoS One; 2019; 14(3):e0214328. PubMed ID: 30908535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients.
    Yamanaka A; Moi ML; Takasaki T; Kurane I; Konishi E
    J Gen Virol; 2017 Feb; 98(2):166-172. PubMed ID: 27911254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Macaca radiata as a non-human primate model of Dengue virus infection.
    Kato F; Ishida Y; Kawakami A; Takasaki T; Saijo M; Miura T; Hishiki T
    Sci Rep; 2018 Feb; 8(1):3421. PubMed ID: 29467430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotype-specific host responses in rhesus macaques after primary dengue challenge.
    Hickey AC; Koster JA; Thalmann CM; Hardcastle K; Tio PH; Cardosa MJ; Bossart KN
    Am J Trop Med Hyg; 2013 Dec; 89(6):1043-57. PubMed ID: 24062475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.
    Buddhari D; Aldstadt J; Endy TP; Srikiatkhachorn A; Thaisomboonsuk B; Klungthong C; Nisalak A; Khuntirat B; Jarman RG; Fernandez S; Thomas SJ; Scott TW; Rothman AL; Yoon IK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3230. PubMed ID: 25329173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing of novel dengue virus 2 vaccines in African green monkeys: safety, immunogenicity, and efficacy.
    Smith KM; Nanda K; Spears CJ; Piper A; Ribeiro M; Quiles M; Briggs CM; Thomas GS; Thomas ME; Brown DT; Hernandez R; McCarl V
    Am J Trop Med Hyg; 2012 Oct; 87(4):743-753. PubMed ID: 22890035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Codon adaptation biases among sylvatic and urban genotypes of Dengue virus type 2.
    Dos Passos Cunha M; Ortiz-Baez AS; de Melo Freire CC; de Andrade Zanotto PM
    Infect Genet Evol; 2018 Oct; 64():207-211. PubMed ID: 29792991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolutionary processes among sylvatic dengue type 2 viruses.
    Vasilakis N; Holmes EC; Fokam EB; Faye O; Diallo M; Sall AA; Weaver SC
    J Virol; 2007 Sep; 81(17):9591-5. PubMed ID: 17553878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.
    Mani S; Tripathi L; Raut R; Tyagi P; Arora U; Barman T; Sood R; Galav A; Wahala W; de Silva A; Swaminathan S; Khanna N
    PLoS One; 2013; 8(5):e64595. PubMed ID: 23717637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of ancestral sylvatic dengue-2 viruses to re-emerge.
    Vasilakis N; Shell EJ; Fokam EB; Mason PW; Hanley KA; Estes DM; Weaver SC
    Virology; 2007 Feb; 358(2):402-12. PubMed ID: 17014880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The history and evolution of human dengue emergence.
    Vasilakis N; Weaver SC
    Adv Virus Res; 2008; 72():1-76. PubMed ID: 19081488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissecting the human serum antibody response to secondary dengue virus infections.
    Patel B; Longo P; Miley MJ; Montoya M; Harris E; de Silva AM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005554. PubMed ID: 28505154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage display demonstrates durable differences in serological profile by route of inoculation in primary infections of non-human primates with Dengue Virus 1.
    Rajan JV; McCracken M; Mandel-Brehm C; Gromowski G; Pollett S; Jarman R; DeRisi JL
    Sci Rep; 2021 May; 11(1):10823. PubMed ID: 34031504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological evidence for transmission of multiple dengue virus serotypes in Papua New Guinea and West Papua prior to 1963.
    Luang-Suarkia D; Ernst T; Alpers MP; Garruto R; Smith D; Imrie A
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005488. PubMed ID: 28437465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral susceptibility of Aedes aegypti (Diptera: Culicidae) from Senegal for dengue serotypes 1 and 3 viruses.
    Gaye A; Faye O; Diagne CT; Faye O; Diallo D; Weaver SC; Sall AA; Diallo M
    Trop Med Int Health; 2014 Nov; 19(11):1355-9. PubMed ID: 25134541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
    Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.